| Sign In to gain access to subscriptions and/or personal tools. |
The Effects of ZENECA ZD8731, an Angiotensin II Antagonist, on Renin Expression by Juxtaglomerular Cells in the Rat: Comparison of Protein and mRNA Expression as Detected by Immunohistochemistry and In Situ HybridizationSafety of Medicines Department, ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG
Department of Pathology, University of Glasgow, Western Infirmary, Glasgow G11 6NT, Scotland
Department of Pathology, University of Glasgow, Western Infirmary, Glasgow G11 6NT, Scotland
Safety of Medicines Department, ZENECA Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG Changes in the mRNA and protein expression of renin-secreting cells in the juxtaglomerular apparatus (JGA) were examined in the rat following administration of ZENECA ZD8731, an angiotensin II receptor antagonist. Doses of 0 or 90 mg/kg were administered daily by gavage for 26 wk. JGA hypertrophy was apparent in histological sections. Immunohistochemistry demonstrated an increase in the number of renin-containing cells in both the afferent arterioles and the interlobular arteries. Similarly, renin mRNA expression, demonstrated by in situ hybridization, had extended to more proximal segments of the afferent arterioles and was also present in efferent arterioles and interlobular arteries. In conclusion, JGA hypertrophy occurred as a result of antagonism of the angiotensin II receptor. Associated with JGA hypertrophy was increased expression of both renin and renin mRNA, indicative of stimulated renin synthesis caused by an exaggerated pharmacological response of renin-secreting cells to the loss of feedback inhibition by angiotensin II.
Key Words: Rat angiotensin II antagonist juxtaglomerular apparatus renin afferent arteriole juxtaglomerular cell hypertrophy
Toxicologic Pathology, Vol. 23, No. 3,
256-261 (1995) This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||



